Diindolylmethane formulations for the treatment of leiomyomas
US8080577B2 · kind B2 · utility
11Cited by
17References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 6, 2005 |
| Grant date | Dec 20, 2011 |
| Priority date | — |
| Expiry date | Nov 9, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/404
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods for treating or preventing leiomyomas by administration of diindolylmethane and diindolylmethane-related indoles. The present invention also relates to compositions and methods for treating or preventing leiomyomas by administration of diindolylmethane in combination with an EGFR antagonist. The methods provide non-invasive treatments for leiomyomas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.